• Thu, February 8, 2024

Naz Rahman Maintained (VKTX) at Strong Buy with Increased Target to $50 on, Feb 8th, 2024

Naz Rahman of Maxim Group, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $35 to $50 on, Feb 8th, 2024.

Naz has made no other calls on VKTX in the last 4 months.



There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Naz's Rating of Hold.



This is the rating of the analyst that currently disagrees with Naz


  • Joon Lee of "Truist Securities" Reiterated at Strong Buy and Held Target at $32 on, Monday, December 4th, 2023

Like: 👍